Fund Holdings — Euclidean Capital LLC

Total Portfolio Value
$369.45M
Total Bought
$135.26M
Total Sold
$0
Net Transaction
+$135.26M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
VANGUARD INDEX FDS0520,000+520,000099,31526.88%+99,315
VANGUARD INTL EQUITY INDEX F2,578,1842,990,084+411,900184,005219,95159.53%+35,946
SURROZEN INC(SRZN)87,69687,69601,1301,9820.54%+852
FOGHORN THERAPEUTICS INC(FHTX)1,573,7611,573,76107,6968,4982.30%+803
ISHARES TR
MSCI INDIA ETF
369,600369,600019,24119,9775.41%+736
RAPT THERAPEUTICS INC82,23482,23402,1212,7850.75%+664
SPDR S&P 500 ETF TR(SPY)4,1044,10402,7342,7990.76%+65
SURROZEN INC(SRZN)170,833170,8330330.00%0
PMV PHARMACEUTICALS INC(PMVP)2,627,6432,627,64303,6793,2850.89%-394
TENAYA THERAPEUTICS INC(TNYA)1,015,7051,015,70501,6457230.20%-923
ALECTOR INC1,307,8581,307,85803,8712,0400.55%-1,831
ORIC PHARMACEUTICALS INC(ORIC)989,410989,410011,8738,0932.19%-3,780
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q4 2025 | TickerTrail